AB Science

AB

Company Profile

  • Business description

    AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

  • Contact

    3, Avenue George V
    Paris75008
    FRA

    T: +33 147200014

    https://www.ab-science.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    39

Stocks News & Analysis

stocks

Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown

We think Amazon stock looks attractive.
stocks

Apple earnings: Strong iPhone beat brings our valuation up and tariff costs prove light for now

We think Apple stock looks fairly valued.
stocks

4 ASX shares that could be vulnerable to an August surprise

Any missteps this reporting season could be costly for these shares, which have all risen to lofty valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,900.7016.40-0.18%
CAC 407,546.16225.81-2.91%
DAX 4023,425.97639.50-2.66%
Dow JONES (US)43,588.58542.40-1.23%
FTSE 1009,068.5864.23-0.70%
HKSE24,507.81265.52-1.07%
NASDAQ20,650.13472.31-2.24%
Nikkei 22539,949.12850.48-2.08%
NZX 50 Index12,734.535.130.04%
S&P 5006,238.01101.38-1.60%
S&P/ASX 2008,646.3015.70-0.18%
SSE Composite Index3,559.9513.26-0.37%

Market Movers